Hydrogen sulphide suppresses human atrial fibroblast proliferation and transformation to myofibroblasts

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 10, 2013, Pages 1345-1354

  Sheng, Jingwei ^a   Shim, Winston ^a,b   Wei, Heming ^a   Lim, Sze Yun ^a   Liew, Reginald ^b   Lim, Tien Siang ^a   Ong, Boon Hean ^a   Chua, Yeow Leng ^a   Wong, Philip ^a,b  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Atrial fibrosis; Fibroblast; Hydrogen sulphide; Potassium channel

Indexed keywords

HYDROGEN SULFIDE; POTASSIUM CHANNEL; PRIMER DNA;

ARTICLE; ATRIAL FIBROSIS; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; FIBROBLAST; HEART ATRIUM; HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

ATRIAL FIBROSIS; FIBROBLAST; HYDROGEN SULPHIDE; POTASSIUM CHANNEL;

BASE SEQUENCE; CELL DIFFERENTIATION; DNA PRIMERS; FIBROBLASTS; HEART ATRIA; HUMANS; HYDROGEN SULFIDE; POLYMERASE CHAIN REACTION;

EID: 84888339614     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12114     Document Type: Article

References (39)

1. Bapat A, Nguyen TP, Lee JH, et al. Enhanced sensitivity of aged fibrotic hearts to angiotensin II- and hypokalemia-induced early afterdepolarization-mediated ventricular arrhythmias. Am J Physiol Heart Circ Physiol. 2012; 302: H2331-40.
2. van Nieuwenhoven FA, Turner NA. The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction. Vascul Pharmacol. 2013; 58: 182-8.
3. Yue L, Xie J, Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res. 2011; 89: 744-53.
4. Teunissen BE, Smeets PJ, Willemsen PH, et al. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts. Cardiovasc Res. 2007; 75: 519-29.
5. Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res. 2002; 91: 1103-13.
6. Tan AY, Zimetbaum P. Atrial fibrillation and atrial fibrosis. J Cardiovasc Pharmacol. 2011; 57: 625-9.
7. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008; 51: 802-9.
8. Akoum N, McGann C, Vergara G, et al. Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant. J Cardiovasc Electrophysiol. 2012; 23: 44-50.
9. 2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure. Am J Physiol Heart Circ Physiol. 2009; 298: H451-6.
10. Peers C, Bauer CC, Boyle JP, et al. Modulation of ion channels by hydrogen sulfide. Antioxid Redox Signal. 2012; 17: 95-105.
11. Tang G, Wu L, Liang W, et al. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol. 2005; 68: 1757-64.
12. Givvimani S, Munjal C, Gargoum R, et al. Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure. J Appl Physiol. 2011; 110: 1093-100.
13. Huang J, Wang D, Zheng J, et al. Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats. Mol Med Report. 2012; 5: 923-8.
14. Wei H, Zhang G, Qiu S, et al. Hydrogen sulfide suppresses outward rectifier potassium currents in human pluripotent stem cell-derived cardiomyocytes. PLoS ONE. 2012; 7: e50641.
15. Li GR, Sun HY, Chen JB, et al. Characterization of multiple ion channels in cultured human cardiac fibroblasts. PLoS ONE. 2009; 4: e7307.
16. + (BKCa) channel opener in vascular smooth muscle cells. Br J Pharmacol. 2006; 149: 1013-21.
17. Lundby A, Jespersen T, Schmitt N, et al. Effect of the I(to) activator NS5806 on cloned K(V)4 channels depends on the accessory protein KChIP2. Br J Pharmacol. 2010; 160: 2028-44.
18. He ML, Liu WJ, Sun HY, et al. Effects of ion channels on proliferation in cultured human cardiac fibroblasts. J Mol Cell Cardiol. 2011; 51: 198-206.
19. Huang L, Li B, Li W, et al. ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity. Carcinogenesis. 2009; 30: 737-44.
20. Choi EK, Chang PC, Lee YS, et al. Triggered firing and atrial fibrillation in transgenic mice with selective atrial fibrosis induced by overexpression of TGF-beta1. Circ J. 2012; 76: 1354-62.
21. Kiryu M, Niwano S, Niwano H, et al. Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model. Europace. 2012; 14: 1206-14.
22. + channels: regulation of a transient outward current by protein kinase C. Am J Physiol Heart Circ Physiol. 2008; 294: H1010-7.
23. + currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am J Physiol Heart Circ Physiol. 2005; 288: H2931-9.
24. Hanna N, Cardin S, Leung TK, et al. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res. 2004; 63: 236-44.
25. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci. 1996; 16: 1066-71.
26. Li L, Bhatia M, Zhu YZ, et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. Faseb J. 2005; 19: 1196-8.
27. Yan H, Du J, Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun. 2004; 313: 22-7.
28. Chatelier A, Mercier A, Tremblier B, et al. A distinct de novo expression of Nav1.5 sodium channels in human atrial fibroblasts differentiated into myofibroblasts. J Physiol. 2012; 590: 4307-19.
29. + influx. Acta Physiol Scand. 2005; 183: 161-9.
30. Kuhlmann CR, Scharbrodt W, Schaefer CA, et al. Discordant effects of nicotine on endothelial cell proliferation, migration, and the inward rectifier potassium current. J Mol Cell Cardiol. 2005; 38: 315-22.
31. Zhong GZ, Li YB, Liu XL, et al. Hydrogen sulfide opens the KATP channel on rat atrial and ventricular myocytes. Cardiology. 2010; 115: 120-6.
32. Fang LP, Lin Q, Tang CS, et al. Hydrogen sulfide suppresses migration, proliferation and myofibroblast transdifferentiation of human lung fibroblasts. Pulm Pharmacol Ther. 2009; 22: 554-61.
33. Perry MM, Hui CK, Whiteman M, et al. Hydrogen sulfide inhibits proliferation and release of IL-8 from human airway smooth muscle cells. Am J Respir Cell Mol Biol. 2011; 45: 746-52.
34. Wang Y, Zhao X, Jin H, et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2009; 29: 173-9.
35. Chunyu Z, Junbao D, Dingfang B, et al. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun. 2003; 302: 810-6.
36. Guo W, Shan B, Klingsberg RC, et al. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. Am J Physiol Lung Cell Mol Physiol. 2009; 297: L864-70.
37. Olson ER, Naugle JE, Zhang X, et al. Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. Am J Physiol Heart Circ Physiol. 2005; 288: H1131-8.
38. Du J, Hui Y, Cheung Y, et al. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels. 2004; 19: 75-80.
39. Du HJ, Tang N, Liu BC, et al. Benzo[a]pyrene-induced cell cycle progression is through ERKs/cyclin D1 pathway and requires the activation of JNKs and p38 mapk in human diploid lung fibroblasts. Mol Cell Biochem. 2006; 287: 79-89.